Image 2_Pharmacogenetic variations and clinical implications of actionable CYP2D6/CYP2C19 variants in Central Indian patients with common mental disorders.tif

Introduction<p>Genetic polymorphisms in CYP2D6 and CYP2C19 significantly influence the metabolism, efficacy, and safety of antidepressant medications. Limited data exist on the prevalence of these actionable pharmacogenetic variants in the Central Indian population. This study aimed to determi...

Full beskrivning

Sparad:

Bibliografiska uppgifter
Huvudupphovsman:	Santenna Chenchula (14775163) (author)
Övriga upphovsmän:	Atal Shubham (22679330) (author), Rozatkar Abhijit (22679333) (author), Tamonud Modak (22679336) (author), Kohat Komal (22679339) (author), Ratinder Jhaj (22679342) (author), Singh Jitendra (22679345) (author), Satyaprakash V. (22679348) (author), Sadasivam Balakrishnan (22679351) (author)
Publicerad:	2025
Ämnen:	Pharmacology pharmacogenetics CYP2D6 CYP2C19 antidepressants common mental disorders indian population copy number variation CPIC
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!

Lägg till första kommentaren!

Image 2_Pharmacogenetic variations and clinical implications of actionable CYP2D6/CYP2C19 variants in Central Indian patients with common mental disorders.tif

Liknande verk